Baudax Bio Balans Gezondheid
Financiële gezondheid criteriumcontroles 0/6
Baudax Bio has a total shareholder equity of $-1.2M and total debt of $5.2M, which brings its debt-to-equity ratio to -436.4%. Its total assets and total liabilities are $20.6M and $21.8M respectively.
Belangrijke informatie
-436.4%
Verhouding schuld/eigen vermogen
US$5.23m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$363.00k |
| Aandelen | -US$1.20m |
| Totaal verplichtingen | US$21.78m |
| Totaal activa | US$20.58m |
Recente financiële gezondheidsupdates
Recent updates
Baudax Bio stock down after pricing $6.2M equity offering
Aug 30Baudax Bio to get US patent linked to pain drug Anjeso
Aug 22Baudax Bio GAAP EPS of -$1.05 beats by $0.22, revenue of $0.3M
Aug 11Cosette Pharmaceuticals appoints Rick Casten as CFO
Jul 06Baudax Bio: Looking For A Turnaround In Strong COVID-19 Headwinds
Sep 09A First Look At Baudax Bio
May 30Baudax Bio EPS misses by $0.08, misses on revenue
May 05Baudax Bio's Anjeso shows efficacy in pain management for total knee arthroplasty
Apr 26Have Insiders Been Buying Baudax Bio, Inc. (NASDAQ:BXRX) Shares?
Feb 17
Baudax Bio EPS of $0.62
Nov 09Baudax Bio: Why I'm Catching This Falling Knife
Nov 03Analyse van de financiële positie
Kortlopende schulden: BXRX.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langlopende schulden: BXRX.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: BXRX.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Schuld verminderen: BXRX.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if BXRX.Q has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if BXRX.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.